| Date Filed | Type | Description |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/01/2023 |
8-K
| Quarterly results |
| 06/15/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 04/27/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/01/2023 |
SC 13D/A
| Nautilus Biotechnology, Inc. reports a 15% stake in Nautilus Biotechnology, Inc. |
| 02/23/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 02/23/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/09/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/02/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/02/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/02/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 06/16/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 06/16/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/03/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/03/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/28/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/31/2022 |
8-K
| Quarterly results |
| 03/02/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 03/02/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/24/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/24/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 02/24/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/14/2022 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 2% stake in Nautilus Biotechnology, Inc. |
| 02/10/2022 |
SC 13G
| VCVC V LLC reports a 5.8% stake in Nautilus Biotechnology, Inc. |
| 12/21/2021 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 11/02/2021 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 11/02/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/25/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/10/2021 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/10/2021 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/10/2021 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/10/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
|